Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
Rafael Dal‐Ré, Odile Launay
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Agency (philosophy)Business2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Regulatory agencyDrug approvalMedicineVirologyPharmacologyPolitical sciencePublic administrationInfectious disease (medical specialty)DiseaseDrugPathologyOutbreakEpistemologyPhilosophySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyPharmacovigilance and Adverse Drug Reactions